Published guidance, NICE advice and quality standards | Guidance

Showing 731 to 740 of 901

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism	TA354	26 August 2015	26 August 2015
Secukinumab for treating moderate to severe plaque psoriasis	TA350	22 July 2015	22 July 2015
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)	TA351	22 July 2015	22 July 2015
Naloxegol for treating opioid‑induced constipation	TA345	22 July 2015	22 July 2015
Aflibercept for treating diabetic macular oedema	TA346	22 July 2015	22 July 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	TA347	22 July 2015	22 July 2015
Everolimus for preventing organ rejection in liver transplantation	TA348	22 July 2015	22 July 2015
Omalizumab for previously treated chronic spontaneous urticaria	TA339	8 June 2015	8 June 2015
Vedolizumab for treating moderately to severely active ulcerative colitis	TA342	5 June 2015	5 June 2015